← Leaderboards
Rukiyah Van Dross
Claradele Pharmaceuticals, Inc.
$398,242
Attributed
$398,242
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$398,242 · 1
By mechanism
R41$398,242 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adverse Effects”
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$12,449,418
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EffectsAnti-Pd-1Anti-Pd1 AntibodiesBaseBiologicalBody WeightC57bl/6 MouseCancer CellCancer Cell LineCd8b1 GeneCd8-Positive T-LymphocytesCessation Of LifeCollaborationsColon CarcinomaCtla4 GeneCytotoxicDacarbazineDendritic Cell ActivationDendritic CellsDendritic Cell TumorDensityDosageDoseAdvanced Disease